IP84-19: Combinatorial Immunotherapy with IL-12/shVEGF-Expressing Oncolytic Adenovirus for Renal Cell Carcinoma: In Vitro, Organ-on-a-Chip, and In Vivo Evaluation

IP84-19: Combinatorial Immunotherapy with IL-12/shVEGF-Expressing Oncolytic Adenovirus for Renal Cell Carcinoma: In Vitro, Organ-on-a-Chip, and In Vivo Evaluation

Monday, May 18, 2026 9:30 AM to 11:30 AM · 1 hr. 59 min. (America/New_York)

147B

Abstract

Sessions

IP84: Kidney Cancer: Basic Research & Pathophysiology

Monday, May 18, 2026 9:30 AM to 11:30 AM

Log in

See all the content and easy-to-use features by logging in or registering!